Background Non-severe adverse events (AE) including pain at injection site or fever are
common after COVID-19 vaccination. Aim To describe determinants of AE after COVID-19 …

The emergence of new variants and diverse vaccination regimens have raised uncertainty
about vaccine effectiveness against SARS-CoV-2. This study aims to investigate the impact …

During the COVID-19 pandemic, heterologous vaccination strategies were employed to
alleviate the strain on vaccine supplies. The Thailand Ministry of Health adopted these …

Identifying parameters influencing SARS-CoV-2 antibody dynamics post infection or
vaccination is crucial for refining vaccination strategies. In a longitudinal analysis of 1340 …

Introduction COVID-19 vaccines are highly effective in inducing protective immunity. While
the serum antibody response to COVID-19 vaccination has been studied in depth, our …

Background After licensing of the protein-based vaccine NVX-CoV2373, three technically
different vaccines against the SARS-CoV-2 became available for application to the human …

Background/Objectives: The emergence of the Omicron variant has complicated COVID-19
control and prompted vaccine updates. Recent studies have shown that a fourth dose …

Abstract Background BBV152 (Covaxin™) is a whole-virion inactivated SARS-CoV-2
vaccine mixed with an immune adjuvant. We aimed to compare immune responses after …

Methods: Measurement of specific plasma IgG antibodies was combined with functional
analyses of antibody-secreting plasmablasts and Bmems. SARS-CoV-2-and HCoV-specific …

OBJECTIVE: To determine IgG levels post-SARS-CoV-2 vaccination with mRNA vaccines
compared to viral vectors and inactivated vaccines. MATERIALS AND METHODS: This …